Bellwether Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.71M Sell
1,858
-272
-13% -$276K 0.29% 77
2025
Q4
$2.29M Buy
+2,130
New +$2.04M 0.37% 54
2025
Q3
Sell
-120
Closed -$93.5K 377
2025
Q2
$93.5K Buy
120
+35
+41% +$27.2K 0.02% 178
2025
Q1
$70.2K Hold
85
0.01% 195
2024
Q4
$65.6K Buy
+85
New +$70.4K 0.01% 209
2023
Q2
Sell
-75
Closed -$25.8K 285
2023
Q1
$25.8K Hold
75
0.01% 230
2022
Q4
$27.4K Sell
75
-73
-49% -$25.9K 0.01% 226
2022
Q3
$47K Buy
+148
New +$46.9K 0.02% 166

Other funds holding LLY

Bellwether Advisors's LLY Position: Q1 2026 in Review

Bellwether Advisors reduced its Eli Lilly (LLY) stake by 13% in Q1 2026, selling an estimated $276K and leaving 1,858 shares worth $1.71M. The position accounts for 0.29% of the portfolio, ranked #77.

Bellwether Advisors first reported a position in LLY in Q3 2022 and has held it in 8 quarters since. The position peaked at $2.29M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Bellwether Advisors held 1,858 shares of Eli Lilly worth $1.71M as of Q1 2026.
  • Bellwether Advisors sold 272 Eli Lilly shares in Q1 2026, an estimated $276K.
  • Eli Lilly made up 0.29% of Bellwether Advisors's portfolio in Q1 2026, its #77 holding.
  • Bellwether Advisors first reported a position in Eli Lilly in Q3 2022 and has held it in 8 quarters since.
  • Bellwether Advisors's Eli Lilly position peaked at $2.29M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Bellwether Advisors's 13F filing for Q1 2026, filed 12 May 2026.